159 related articles for article (PubMed ID: 9852103)
1. The box-1 region of the leukemia inhibitory factor receptor alpha-chain cytoplasmic domain is sufficient for hemopoietic cell proliferation and differentiation.
Zhang Y; Willson T; Metcalf D; Cary D; Hilton DJ; Clark R; Nicola NA
J Biol Chem; 1998 Dec; 273(51):34370-83. PubMed ID: 9852103
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles for leukemia inhibitory factor receptor alpha-chain and gp130 in cell type-specific signal transduction.
Starr R; Novak U; Willson TA; Inglese M; Murphy V; Alexander WS; Metcalf D; Nicola NA; Hilton DJ; Ernst M
J Biol Chem; 1997 Aug; 272(32):19982-6. PubMed ID: 9242667
[TBL] [Abstract][Full Text] [Related]
3. The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation. Involvement of STAT3.
Ernst M; Novak U; Nicholson SE; Layton JE; Dunn AR
J Biol Chem; 1999 Apr; 274(14):9729-37. PubMed ID: 10092661
[TBL] [Abstract][Full Text] [Related]
4. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
[TBL] [Abstract][Full Text] [Related]
5. An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M.
Vernallis AB; Hudson KR; Heath JK
J Biol Chem; 1997 Oct; 272(43):26947-52. PubMed ID: 9341130
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic domains of the leukemia inhibitory factor receptor required for STAT3 activation, differentiation, and growth arrest of myeloid leukemic cells.
Tomida M; Heike T; Yokota T
Blood; 1999 Mar; 93(6):1934-41. PubMed ID: 10068666
[TBL] [Abstract][Full Text] [Related]
7. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
[TBL] [Abstract][Full Text] [Related]
8. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
9. Direct synergistic effects of leukemia inhibitory factor on hematopoietic progenitor cell growth: comparison with other hematopoietins that use the gp130 receptor subunit.
Keller JR; Gooya JM; Ruscetti FW
Blood; 1996 Aug; 88(3):863-9. PubMed ID: 8704242
[TBL] [Abstract][Full Text] [Related]
10. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
Hui W; Bell M; Carroll G
Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
[TBL] [Abstract][Full Text] [Related]
11. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
12. Involving of the cytoplasmic region of leukemia inhibitory factor receptor alpha subunit, IL-6 related signal transducer-gp130 or fas death domain for MAPK p42/44 activation in HL-60 cell with LIF or anti-Fas IgG.
Liu H; Dan J; Tang S; Wu S
Mol Cell Biochem; 2001 Jan; 217(1-2):113-20. PubMed ID: 11269654
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells.
Tomida M
Leuk Lymphoma; 2000 May; 37(5-6):517-25. PubMed ID: 11042511
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit.
Tanaka M; Hara T; Copeland NG; Gilbert DJ; Jenkins NA; Miyajima A
Blood; 1999 Feb; 93(3):804-15. PubMed ID: 9920829
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase.
Blanchard F; Duplomb L; Wang Y; Robledo O; Kinzie E; Pitard V; Godard A; Jacques Y; Baumann H
J Biol Chem; 2000 Sep; 275(37):28793-801. PubMed ID: 10858440
[TBL] [Abstract][Full Text] [Related]
16. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
Mosley B; De Imus C; Friend D; Boiani N; Thoma B; Park LS; Cosman D
J Biol Chem; 1996 Dec; 271(51):32635-43. PubMed ID: 8999038
[TBL] [Abstract][Full Text] [Related]
17. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor.
Gearing DP; Ziegler SF; Comeau MR; Friend D; Thoma B; Cosman D; Park L; Mosley B
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1119-23. PubMed ID: 8302840
[TBL] [Abstract][Full Text] [Related]
18. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G
FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of signaling events mediated by the cytoplasmic domain of leukemia inhibitory factor receptor alpha subunit.
Liu H; Liu S; Tang S; Ji K; Wang F; Hu S
Mol Cell Biochem; 2004 Mar; 258(1-2):15-23. PubMed ID: 15030166
[TBL] [Abstract][Full Text] [Related]
20. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.
Heymann D; Godard A; Raher S; Bentouimou N; Blanchard F; Cherel M; Hallet MM; Jacques Y
Cytokine; 1996 Mar; 8(3):197-205. PubMed ID: 8833034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
